{
    "clinical_study": {
        "@rank": "117839", 
        "acronym": "Bionect", 
        "arm_group": [
            {
                "arm_group_label": "Control", 
                "arm_group_type": "No Intervention", 
                "description": "No use of Bionecteur; handling according to institutional guideline"
            }, 
            {
                "arm_group_label": "Bionecteur", 
                "arm_group_type": "Active Comparator", 
                "description": "Use of Bionecteur; handling according to institutional guideline"
            }
        ], 
        "brief_summary": {
            "textblock": "Bionecteur\u00ae is a protective non-touch applicator to ensure aseptic connection made by Vygon.\n      However, there are no studies describing a positive effect of using Bionecteurs \u00ae in regard\n      to catheter-related bloodstream infections. In this study Bionecteur\u00ae will be used on\n      central venous lines and arterial lines in postoperative patients of a 40-bed ICU. The\n      incidence of catheter-related bloodstream infections will we compared to patients without\n      inclusion of Bionecteur\u00ae devices."
        }, 
        "brief_title": "Influence of Bionecteurs on Catheter-associated Infection", 
        "completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Infection", 
        "condition_browse": {
            "mesh_term": "Catheter-Related Infections"
        }, 
        "detailed_description": {
            "textblock": "-  Prospective, randomised observational study\n\n        -  Postsurgical patients in an anesthesiological ICU with ICU LOS  (LOS: length of stay) >\n           3 days\n\n             -  Inclusion:\n\n                ---- Age \u2265 18 years\n\n                ---. demand of central venous and arterial line\n\n                ---  written consent of patient and/or assignee\n\n             -  Exclusion\n\n                  -  Handicapped patients\n\n                  -  patient with ICU LOS < 3 days\n\n        -  Study design\n\n             1. Three days after admission to ICU blood cultures are drawn to exclude preexisting\n                blood stream infection\n\n             2. Patients in a bed with even number are assigned to Bionecteur\u00ae group. Control\n                group (without using bionecteurs) are patients with an odd bed number.\n\n             3. Biconecteurs\u00ae are connected to all lumens of the central catheter and to arterial\n                catheter. Control group is treated without using Bionecteurs\u00ae. Handling of\n                vascular catheters are performed as described in institutional guidelines in both\n                groups.\n\n             4. Catheter-related bloodstream infections are monitored by an independent person\n                during ICU treatment\n\n             5. The study will be finished ab discharge of ICU or removal of catheters."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Length of Stay (LOS) in  ICU > 3 days\n\n          -  written consent by patient or notarial carers\n\n          -  medical indication for central venous line/arterial line\n\n        Exclusion Criteria:\n\n          -  handicap\n\n          -  LOS ICU < 3 days\n\n          -  no consent"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 9, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02134769", 
            "org_study_id": "BIONECT-2014", 
            "secondary_id": "ZVK-Bionect"
        }, 
        "intervention": {
            "arm_group_label": "Bionecteur", 
            "description": "Using Bionecteur at each lumina of the catheter; handling according to institutional guideline", 
            "intervention_name": "Bionecteur", 
            "intervention_type": "Device", 
            "other_name": "bionector\u00ae company: Vygon"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "catheter-related bloodstream infections", 
        "lastchanged_date": "May 7, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Tuebingen", 
                    "country": "Germany", 
                    "zip": "72076"
                }, 
                "name": "University Hospital Tuebingen"
            }, 
            "investigator": {
                "last_name": "Helene A Haeberle, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "2", 
        "official_title": "Incidence of Catheter-related Bloodstream Infections Using Bionecteur Device", 
        "overall_contact": {
            "email": "helene.haeberle@med.uni-tuebingen.de", 
            "last_name": "Helene A Haeberle, MD", 
            "phone": "+49 (0) 7071-298", 
            "phone_ext": "6900"
        }, 
        "overall_contact_backup": {
            "email": "peter.rosenberger@med.uni-tuebingen.de", 
            "last_name": "Peter Rosenberger, Prof.", 
            "phone": "+49 (0) 7071-298", 
            "phone_ext": "6622"
        }, 
        "overall_official": {
            "affiliation": "University Hospital Tuebingen, Germany", 
            "last_name": "Helene A Haeberle, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Incidence of catheter-related bloodstream infections using Bionecteurs", 
            "safety_issue": "Yes", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02134769"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Determine days in ICU with centrral venous catheter", 
            "measure": "Length of Stay in ICU", 
            "safety_issue": "Yes", 
            "time_frame": "1 year"
        }, 
        "source": "University Hospital Tuebingen", 
        "sponsors": {
            "collaborator": {
                "agency": "Vygon GmbH & Co. KG", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "University Hospital Tuebingen", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}